MapLight Therapeutics, Inc.
MPLT
55 insider filings · Latest: Aug 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Feb 13 9:08 PM | ROBERT MALENKA | Proposed Sale | 12,116 | $18.21 | $220.7K | — | View → |
| Feb 10, 2026 | Feb 12 10:45 PM | Timothy John GarnettDirector | Purchase | 14,124 | $17.89 | $252.7K | 14,124(I) | View → |
| Feb 11, 2026 | Feb 12 10:45 PM | Robert C. MalenkaDirector | Sale | 241 | $18.00 | $4.3K | 351,370(D) | View → |
| Feb 10, 2026 | Feb 12 10:45 PM | Robert C. MalenkaDirector | Sale | 6,622 | $18.12 | $120.0K | 351,611(D) | View → |
| Feb 11, 2026 | Feb 11 9:13 PM | ROBERT MALENKA | Proposed Sale | 241 | $18.00 | $4.3K | — | View → |
| Feb 10, 2026 | Feb 10 9:22 PM | ROBERT MALENKA | Proposed Sale | 6,622 | $18.12 | $120.0K | — | View → |
| Feb 3, 2026 | Feb 5 2:15 AM | Robert C. MalenkaDirector | Sale | 1 | $18.00 | $18 | 358,233(D) | View → |
| Feb 2, 2026 | Feb 5 2:15 AM | Robert C. MalenkaDirector | Sale | 7,039 | $18.02 | $126.8K | 358,234(D) | View → |
| Feb 3, 2026 | Feb 3 9:15 PM | ROBERT MALENKA | Proposed Sale | 1 | $18.00 | $18 | — | View → |
| Feb 2, 2026 | Feb 2 9:37 PM | ROBERT MALENKA | Proposed Sale | 7,039 | $18.02 | $126.8K | — | View → |
| Jan 30, 2026 | Jan 31 1:50 AM | Robert C. MalenkaDirector | Sale | 6,612 | $18.11 | $119.7K | 365,273(D) | View → |
| Jan 29, 2026 | Jan 31 1:50 AM | Robert C. MalenkaDirector | Sale | 21,262 | $18.55 | $394.4K | 371,885(D) | View → |
| Jan 28, 2026 | Jan 31 1:50 AM | Robert C. MalenkaDirector | Sale | 6,524 | $18.65 | $121.7K | 393,147(D) | View → |
| Jan 30, 2026 | Jan 30 9:17 PM | ROBERT MALENKA | Proposed Sale | 6,612 | $18.11 | $119.7K | — | View → |
| Jan 29, 2026 | Jan 29 9:06 PM | ROBERT MALENKA | Proposed Sale | 21,262 | $18.55 | $394.5K | — | View → |
| Jan 28, 2026 | Jan 28 9:20 PM | ROBERT MALENKA | Proposed Sale | 6,524 | $18.65 | $121.7K | — | View → |
← Previous
Page 6 of 6
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 25 10:04 PM | Troy CoxDirector | Grant/Award | 29,804 | $28.64 | 29,804(D) | View → |
| Jun 23, 2026 | Jun 25 10:01 PM | Martin BablerDirector | Grant/Award | 29,804 | $28.64 | 29,804(D) | View → |
| Jun 23, 2026 | Jun 25 9:59 PM | Timothy John GarnettDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:57 PM | Nanna Liebach LuneborgDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:54 PM | George PavlovDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Jun 23, 2026 | Jun 25 9:52 PM | Maria C WalkerDirector | Grant/Award | 14,902 | $28.64 | 14,902(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Jonathan GillisCAAO and PAO | Grant/Award | 24,455 | $15.70 | 24,455(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Vishwas SetiaChief Financial Officer | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | James Woodruff LillieChief Scientific Officer | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Anatol KreitzerChief Discovery Officer | Grant/Award | 24,455 | $15.70 | 24,455(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Kristopher HansonGeneral Counsel | Grant/Award | 31,395 | $15.70 | 31,395(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Erin Pennock FoffChief Medical Officer | Grant/Award | 54,240 | $15.70 | 54,240(D) | View → |
| Feb 5, 2026 | Feb 9 10:50 PM | Christopher A. KroegerDirector, Chief Executive Officer | Grant/Award | 93,955 | $15.70 | 93,955(D) | View → |